About Nucleic Acid Isolation and Purification
Isolation and purification of nucleic acids, deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), is the basic technique used in molecular biology. These biomolecules can be isolated from any biological material for consequent downstream, analytical, or preparative purposes. The demand for DNA fingerprinting, construction of genomic or sequencing libraries, restriction fragment length polymorphism (RFLP), and polymerase chain reaction (PCR) analysis in research laboratories and industries has increased. Also, nucleic acid isolation and purification is the first step in the study of specific DNA and RNA sequences, and in the analysis of genome structure and gene expression. However, the quantity, quality, and integrity of nucleic acids will directly affect these results.
Technavio’s analysts forecast the global nucleic acid isolation and purification market to grow at a CAGR of 8.33% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global nucleic acid isolation and purification market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Nucleic Acid Isolation and Purification Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Agilent Technologies
• Bio-Rad Laboratories
• F.Hoffmann-La-Roche
• GE Healthcare
• Thermo Fisher Scientific
Other prominent vendors
• Abcam
• Bioline
• biotechrabbit
• bioWORLD
• Danaher
• Epicentre
• Hamilton
• New England Biolabs
• Omega Bio-tek
• Promega
• Qiagen
• Sigma-Aldrich
• Takara Bio
Market driver
• Increasing occurrence of genetic disorder, cancer, and infectious diseases
• For a full, detailed list, view our report
Market challenge
• Intense competition between local and global vendors
• For a full, detailed list, view our report
Market trend
• Increasing importance of promotional activities
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
• Market outline
PART 05: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 06: MARKET SIZING
• Market definition
• Market sizing 2016
• Market size and forecast 2016-2021
PART 07: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 08: MARKET SEGMENTATION BY END-USER
• Segmentation by end-user
• Comparison by end-user
• Academic and research institutes
• Pharmaceutical and biotechnology companies
• Others
• Market opportunity by end-user
PART 09: GEOGRAPHICAL SEGMENTATION
• Geographical segmentation
• Regional comparison
• Americas
• EMEA
• APAC
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Increasing importance of promotional activities
• Increase in initiatives to promote molecular research
• Increased availability of automated products
PART 13: VENDOR LANDSCAPE
• Competitive scenario
• Investment opportunity
PART 14: VENDOR ANALYSIS
• Vendor overview
• Agilent Technologies
• Bio-Rad Laboratories
• F. Hoffmann-La Roche
• GE Healthcare
• Thermo Fisher Scientific
• Other prominent vendors
PART 15: APPENDIX
• List of abbreviations
List of Exhibits
• Exhibit 01: Parent market
• Exhibit 02: Global nucleic acid isolation and purification market
• Exhibit 03: Market characteristics
• Exhibit 04: Market segments
• Exhibit 05: Market definition: Inclusions and exclusions checklist
• Exhibit 06: Market size 2016
• Exhibit 07: Validation techniques employed for market sizing 2016
• Exhibit 08: Global nucleic acid isolation and purification market 2016-2021 ($ mn)
• Exhibit 09: Global nucleic acid isolation and purification market: Year-over-year growth 2017-2021 (%)
• Exhibit 10: Five forces analysis 2016
• Exhibit 11: Five forces analysis 2021
• Exhibit 12: Bargaining power of buyers
• Exhibit 13: Bargaining power of suppliers
• Exhibit 14: Threat of new entrants
• Exhibit 15: Threat of substitutes
• Exhibit 16: Threat of rivalry
• Exhibit 17: Market condition: Five forces 2016
• Exhibit 18: Market condition: Five forces 2021
• Exhibit 19: Global nucleic acid isolation and purification market by end-user 2016-2021 (%)
• Exhibit 20: Comparison by end-user
• Exhibit 21: Global nucleic acid isolation and purification market by academic and research institutes 2016-2021 ($ mn)
• Exhibit 22: Global nucleic acid isolation and purification market by academic and research institutes: Year-over-year growth 2017-2021 (%)
• Exhibit 23: Global nucleic acid isolation and purification market by pharmaceutical and biotechnology companies 2016-2021 ($ mn)
• Exhibit 24: Global nucleic acid isolation and purification market by pharmaceutical and biotechnology companies: Year-over-year growth 2017-2021 (%)
• Exhibit 25: Global nucleic acid isolation and purification market by others 2016-2021 ($ mn)
• Exhibit 26: Global nucleic acid isolation and purification market by others: Year-over-year growth 2017-2021 (%)
• Exhibit 27: Market opportunity by end-user
• Exhibit 28: Global nucleic acid isolation and purification market 2016-2021
• Exhibit 29: Regional comparison
• Exhibit 30: Nucleic acid isolation and purification market in Americas 2016-2021 ($ mn)
• Exhibit 31: Nucleic acid isolation and purification market in Americas: Year-over-year growth 2017-2021 (%)
• Exhibit 32: Top 3 countries in Americas
• Exhibit 33: Nucleic acid isolation and purification market in EMEA 2016-2021 ($ mn)
• Exhibit 34: Nucleic acid isolation and purification market in EMEA: Year-over-year growth 2017-2021 ($ mn)
• Exhibit 35: Top 3 countries in EMEA
• Exhibit 36: Nucleic acid isolation and purification market in APAC 2016-2021 ($ mn)
• Exhibit 37: Nucleic acid isolation and purification market in APAC: Year-over-year growth
• Exhibit 38: Top 3 countries in APAC
• Exhibit 39: Strategic success factors for vendors
• Exhibit 40: Investment opportunity mapping
• Exhibit 41: Agilent Technologies: Profile
• Exhibit 42: Agilent Technologies: Strength analysis
• Exhibit 43: Agilent Technologies: Strategy assessment
• Exhibit 44: Agilent Technologies: Opportunity assessment
• Exhibit 45: Bio-Rad Laboratories: Profile
• Exhibit 46: Bio-Rad Laboratories: Strength analysis
• Exhibit 47: Bio-Rad Laboratories: Strategy assessment
• Exhibit 48: Bio-Rad Laboratories: Opportunity assessment
• Exhibit 49: F. Hoffmann-La Roche: Profile
• Exhibit 50: F. Hoffmann-La Roche: Strength analysis
• Exhibit 51: F. Hoffmann-La Roche: Strategy assessment
• Exhibit 52: F. Hoffmann-La Roche: Opportunity assessment
• Exhibit 53: GE Healthcare: Profile
• Exhibit 54: GE Healthcare: Strength analysis
• Exhibit 55: GE Healthcare: Strategy assessment
• Exhibit 56: GE Healthcare: Opportunity assessment
• Exhibit 57: Thermo Fisher Scientific: Profile
• Exhibit 58: Thermo Fisher Scientific: Strength analysis
• Exhibit 59: Thermo Fisher Scientific: Strategy assessment
• Exhibit 60: Thermo Fisher Scientific: Opportunity assessment
